Bruker Corporation (BRKR : NASDAQ)
Common Stock
$60.67
USD
+0.00 (%)
Last updated: 2026-09-17
Get BRKR alerts:
BRKR
Bruker Corporation
WealthAwesomePerformance
1 Day
+8.83%
1 Week
+11.46%
1 Month
+5.20%
YTD
+10.95%
Key Statistics
Market Cap
$9.24B
52W High
$65.30
52W Low
$29.99
P/E Ratio
-
50 Day MA
$58.07
200 Day MA
$48.35
Beta
1.26
Dividend Yield
0.36%
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/17/2026 | $61.90 | $64.42 | $61.30 | $63.05 | $63.05 | 3,075,049 |
| 9/16/2026 | $56.64 | $61.72 | $56.61 | $60.67 | $60.67 | 4,105,637 |
| 9/15/2026 | $52.87 | $56.34 | $52.86 | $55.75 | $55.75 | 3,010,328 |
| 9/14/2026 | $53.11 | $53.62 | $51.54 | $52.66 | $52.66 | 2,784,968 |
| 9/11/2026 | $53.77 | $54.33 | $53.08 | $53.43 | $53.43 | 2,091,333 |
| 9/10/2026 | $53.21 | $54.31 | $52.58 | $53.56 | $53.56 | 1,882,900 |
| 9/9/2026 | $57.93 | $58.01 | $53.46 | $54.43 | $54.43 | 2,959,900 |
| 9/8/2026 | $57.58 | $58.57 | $56.80 | $58.37 | $58.37 | 1,040,700 |
| 9/4/2026 | $59.32 | $59.79 | $58.26 | $58.50 | $58.50 | 1,334,200 |
| 9/3/2026 | $59.82 | $60.29 | $57.47 | $59.41 | $59.41 | 1,208,600 |
Analyst Price Targets
Based on 14 analysts covering BRKR · as of Sep 17, 2026
Wall Street analysts forecast BRKR stock price to fall 2.4% over the next 12 months.
Consensus
Buy3.86 / 5.00
Avg. Target
US$59.23
-2.4% Upside
Current Price
US$60.67
Last close
Analyst Breakdown (14 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BRKR's historical volatility
30-Day Vol
54.5%
Annualized
90-Day Vol
72.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$75.38
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$66.92 | US$55.44 – US$80.77 |
| 60 trading days | US$71.02 | US$54.43 – US$92.68 |
| 90 trading days | US$75.38 | US$54.41 – US$104.42 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Bruker Corporation
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
Financials
- Revenue (TTM)
- $3.50B
- EBITDA
- $541.10M
- Profit Margin
- -2.04%
- ROE (TTM)
- -3.00%
- EPS (Diluted)
- -0.76
- Book Value
- 15.63
Classification
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About BRKR.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| DLXY | Delixy Holdings Limited Ordinary Shares | $2.29 | +451.81% |
| MEDS | DataMEDS AI, Inc. | $6.07 | +274.69% |
| SNYR | Synergy CHC Corp. Common Stock | $0.27 | +234.15% |
| QCLS | Q/C Technologies, Inc. | $0.96 | +118.45% |
| AEHL | Antelope Enterprise Holdings Ltd | $9.22 | +78.68% |
| ZTG | Zenta Group Company Limited | $1.18 | +75.33% |
| PDSB | PDS Biotechnology Corp | $0.99 | +69.25% |
| TPST | Tempest Therapeutics Inc | $1.21 | +60.18% |
BRKR.US news timeline
1 article covering BRKR.US, most recent first
Latest